Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCSK9 Inhibitor in Aortic Stenosis
NCT03051360Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, randomised trial in aortic stenosis (AS) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Progression of the Calcium score measured by cardiac CT (Agatston score) and by NaF PET at 2 years. Status: unknown.
02
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT03051360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051360.